Cleveland Clinic’s Glickman Urological & Kidney Institute, which is ranked second in the nation for urology and nephrology, has received $2 million from Eugene and Zara Shvidler in support of nephrology and hypertension research. Their gift establishes The Shvidler Endowed Chair in Nephrology and Hypertension Research, which will be used to support current and future research projects at Cleveland Clinic.
The first chair holder is Michael Lioudis, MD, of Glickman’s Department of Nephrology and Hypertension. Dr. Lioudis’ specialties include hemodialysis, chronic kidney disease, resistant hypertension and renal diseases.
“I commend Dr. Lioudis for his efforts in making the endowed chair a reality,” says Rob Heyka, MD, Chair of the Department of Nephrology and Hypertension. “I also congratulate Mr. Shvidler for his insight and interest in these important medical problems. The endowed chair will allow us to support research to investigate critical issues in hypertension and kidney disease and have a significant impact on the care of patients.”
Toby Cosgrove, MD, CEO and President of Cleveland Clinic, says, “We are tremendously grateful to Eugene and Zara Shvidler for their support. Gifts such as theirs provide the flexibility to invest in and develop leading-edge initiatives and technology that benefit patients around the world.”
Endowed chairs allow chair holders to start new projects, support additional staff, pay for equipment and cover the cost of experiments, and they are incentives in recruiting and retaining top researchers. They are a tribute to the fine work of Cleveland Clinic physicians and researchers.
Endowed chairs also support the collection of preliminary data by chair holders, an important step in obtaining new outside funding. The endowment revenue also may support investigations into which patients will benefit most from new treatment approaches.
“I am greatly appreciative of Mr. Shvidler’s generous endowment to the Cleveland Clinic,” Dr. Lioudis says. “Mr. Shvidler has a vision of improving the health of individuals all around the world, and we will use this chair to fulfill this mission.”